End Use - Cancer Monoclonal Antibodies Market Statistics
The global end use cancer monoclonal antibodies market size was valued at US$ 80,031.2 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 11.8% from 2023 to 2030.